# OnCo record lymphoma-decision-beacopp-or-abvd (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/lymphoma-decision-beacopp-or-abvd/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "lymphoma-decision-beacopp-or-abvd" ;
  schema:name "Escalated chemotherapy or ABVD in advanced Hodgkin lymphoma: more cures, more late harm, and what the interim scan changed"@en ;
  schema:alternateName "BEACOPP or ABVD"@en, "Escalated BEACOPP decision"@en, "BrECADD decision"@en, "PET-adapted Hodgkin treatment"@en ;
  schema:description "Advanced Hodgkin lymphoma can be treated with a gentler combination that fewer people are cured by first time, or a harder one that cures more but leaves more lasting harm. Scanning after two cycles, and the newer escalated regimens, have narrowed the gap between the two rather than settled the argument."@en ;
  schema:url <https://onco.cc/terms/lymphoma-decision-beacopp-or-abvd/> ;
  schema:dateModified "2026-10-01"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1510093>, <https://doi.org/10.1016/S0140-6736(24)01315-1>, <https://doi.org/10.1056/NEJMoa1505949>, <https://doi.org/10.1001/jamainternmed.2015.1180>, <https://doi.org/10.1200/JCO.2012.44.3721>, <https://lymphoma-action.org.uk/information-and-support/types-lymphoma/hodgkin-lymphoma/classical-hodgkin-lymphoma>, <https://lymphoma-action.org.uk/information-and-support/side-effects-lymphoma-and-treatment/late-effects-lymphoma-treatment>, <https://www.nhs.uk/conditions/hodgkin-lymphoma/treatment/> ;
  onco:cancers <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/advanced-stage-classical-hodgkin-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/pet-adapted-therapy/>, <https://onco.cc/technologies/fertility-preservation/> ;
  onco:terms <https://onco.cc/terms/lymphoma-tx-hodgkin-late-effects/>, <https://onco.cc/terms/deauville/>, <https://onco.cc/terms/lymphoma-living-hodgkin-survivorship-screening/>, <https://onco.cc/terms/lymphoma-decision-fertility-timing/>, <https://onco.cc/terms/secondary-malignancy/>, <https://onco.cc/terms/cardiotoxicity/> ;
  onco:trials <https://onco.cc/trials/rathl/>, <https://onco.cc/trials/hd21/>, <https://onco.cc/trials/swog-s1826/>, <https://onco.cc/trials/echelon-1/> .